New Treatment Strategy Enables Kidney Transplant for High-Risk Patient, Published in NEJM

An international research team has reported a new treatment strategy that facilitated a successful kidney transplant for a patient with a highly unfavorable immunological profile, who previously had no realistic chance of receiving a suitable donor organ. The strategy, published in the New England Journal of Medicine, involves using the cancer drug Teclistamab to significantly reduce antibodies against potential transplants.